TOBIpodhaler
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Rush University Medical Center
Overview
TOBIpodhaler is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
TOBIpodhaler clinical trials
Explore related
Medical disclaimer. This page summarizes research about TOBIpodhaler for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.